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Analysis of epidermal growth factor (’25J-EGF) binding to human red cells revealed the 
presence of two classes of binding sites with apparent equilibrium dissociation constants 
(app.K,) in the 10-‘0-10-9 M and in the lo-’ M range, respectively. The number of binding 
siteskell ranged between 600 and 2,400 for the high-affinity binding site and between 
7,200 and 23,000 for the low-affinity site. No differences were seen in the apparent K, 
values for both types of binding sites between red cells obtained from donors with 
different ABO-blood groups. An increase in the number of high affinity EGF binding sites 
was observed in donors with blood group A,-erythrocytes as compared to red cells taken 
from donors with blood groups 0 and B. 
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INTRODUCTION 
Binding sites for the epidermal growth factor (EGF) 
have been described for a great variety of different cell 
types (for a review see [l]) .  Specific binding to plasma 
cell membranes is thought to be due to interaction of the 
growth factor with its receptor, a 170 kDa membrane 
protein whose structure has been studied in great detail 
especially in A 43 1 cells [ 11. The extracellular portion of 
the EGF receptor contains several oligosaccharide chains 
which, at least in the case of A 431 cells, has been shown 
to contain terminal blood group A antigen-like sugar res- 
idues [2,3]. A recent study indicates that modification of 
these terminal sugar residues may alter both interaction of 
EGF with its high affinity binding site as well as the 
kinase activity of the receptor [4]. 
The detection of the presence of binding sites for EGF 
on human erythrocytes (see Results) prompted us to in- 
vestigate the ABO-blood group dependence of EGF bind- 
ing to these cells. Several human red cell membrane 
proteins and membrane lipids are known to bear oligosac- 
charide chains with ABH-antigen-like properties [5] .  We 
hypothesized that, in analogy to the EGF receptor of 
A 43 1 cells, the putative EGF receptor of human erythro- 
cytes might well be equipped with ABH-antigen-like 
sugar residues. Since erythrocytes with different ABH- 
antigens are believed to differ only in the composition of 
the protein and lipid attached sugar chains, donors with 
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different ABO-blood groups may serve as “biological 
variants” for the study of the influence of ABH-antigens 
on binding of EGF to these cells. 
MATERIALS AND METHODS 
Venous blood anticoagulated by heparin was drawn 
from apparently healthy donors. Red cells were washed 
four times with 10 vol of a solution containing 140 mM 
NaCl, 5 mM KCl, 5 mM glycylglycine, 5 mM glucose, 
0.2 mM MgCl,, 1.25 mM CaC1, (pH 7 . 5 9 ,  referred to as 
Na buffer throughout. 
Cells were counted under a light microscope (Neu- 
bauer chamber); 50 (~.l of packed red cells were incubated 
(in triplicates) for 3 hr at 4°C with 12 concentrations of 
‘251-EGF (Amersham-Buchler, Braunschweig, Ger- 
many, specific activity 0.76 Ciimmol) in the range be- 
tween 1 .0 X lOW9-2 X M, the total reaction volume 
amounting to 500 ~ 1 .  The reaction was started by manual 
addition of the red cell suspension and stopped by centrif- 
ugation for 10 min at 10,000g in an Eppendorf-Hermle 
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centrifuge Model Z 380 (Eppendorf, Hamburg, Ger- 
many). Cells were quickly washed three times at 4°C with 
ice-cold Na buffer. Radioactivity of the pellets (total 
binding) was assessed by gamma-counting. Unspecific 
binding as determined in the presence of an excess of 
unlabelled EGF (1.6 X M) was found to be less than 
30% of total binding for both types of binding sites. 
Pipetting was performed by a Tecan Robotic Sample 
processor Model 5052 (dual arm system, Tecan AG, 
Frankfurt, Germany) as described in [6]. For all experi- 
ments given in Results the following binding equation for 
two independent classes of binding sites [7] was fitted to 
the data by nonlinear regression analysis yielding esti- 
mates of the binding parameters for a high- and a low- 
affinity binding site. 
where B,,, , K,, are the high-affinity binding site param- 
eters, Bm2, K,, are the low-affinity binding site parame- 
ters, cf, ch are free and bound concentration of ligand, 
and C is the constant (correcting for unspecific binding). 
The above equation gives an estimate of the specific 
binding of a ligand to two independent binding sites (first 
two terms on the right side of the equation). The constant 
C is used to correct for any linear portion of total binding 
(indicative of unspecific binding) remaining after fitting 
the data to the parameters for two saturating binding 
curves. 
RESULTS 
Nonlinear regression analysis revealed the presence of 
two types of binding sites for the epidermal growth factor 
(EGF) on human erythrocytes (Fig. 1): a high-affinity 
binding site with an apparent equilibrium dissociation 
constant in the 10-lo-lO-y M range (0.2-4.3 X lo-’ M) 
and about 1,000 sitedcell (58&2,400) and a low-affinity 
binding site with an apparent equilibrium dissociation 
constant in the lo-’ M range (1.8-5.7 X lo-’ M) and 
around 10,000 sitedcell (7,20@23,000). 
No considerable differences in app. K, values were 
observed between donors with different ABO-blood 
groups for both types of binding sites. A, erythrocytes 
exhibited a higher number of binding sites for EGF as 
compared to red cells taken from individuals with blood 
groups 0 and B (Tab. I),  the increase being more promi- 
nent for the high affinity binding site (Tab. I). 
DISCUSSION 
The results of the present study indicate that human red 
cells bear two (hitherto unknown) classes of independent 
binding sites for epidermal growth factor (EGF), in ac- 
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Fig. 1. Binding isotherm for the binding of lZ51-EGF to hu- 
man red blood cells in a concentration range between 1 .O x 
lo- ’  and 2 x lop7 M. A: Direct plot of the binding data. B: 
Scatchard plot: A mathematical model of two classes of 
saturable binding sites was iteratively fitted to the binding 
data. The position of the data suggests two classes of inde- 
pendent binding sites (high- and low-affinity binding). 
cordance with results obtained on several other cell types 
[I]. A recent report indicates that the most abundant 
membrane protein present in human erythrocytes, the 
band 3 protein, is a fairly good substrate for the EGF 
receptor associated tyrosine kinase [8]. In addition, we 
observed in human erythrocytes a Ca inward transport 
susceptible towards inhibition by the phorbol ester TPA 
[9]. Thus, there is both direct and indirect evidence that 
EGF elicits intracellular responses in human erythro- 
cytes. 
The EGF receptor of A 431 cells has been shown to 
bear ABH-blood group antigen-like sugar structures [2,3] 
which may influence binding of the growth factor to its 
receptor [4]. In the study of Defize et al. [4], the lack of 
blood group antigen A on A43 1 cells was associated with 
an increased number of high affinity receptors for EGF. 
In contrast, in the present study, the amount of high- 
affinity binding sites for EGF on human erythrocytes was 
higher in blood group A, as compared to blood group B 
and 0 erythrocytes (Table I). However, observations re- 
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TABLE 1. EGF Binding to Erythrocytes of Healthy Donors With Different ABO Blood Groups* 
EGF binding 
High-affinity site Low-affinity site 
app. Kd app. Kd 
Blood group B,, M) Bm,x (lo-' M) 
0 960 f 680 1.7 f 1.2 10,900 f 5,200 4.3 f 1.3 
A I  1,830 f 900 1.5 f 2.0 14,700 * 5,600 3.7 f 1.6 
4.2 f 2.2 B 950 f 390 1.3 f 0.3 
(n = 6 )  
(n = 4) 
(n = 3) 
10,500 f 8,500 
*Red cells were treated with different concentrations of EGF for 3 h at 4OC as described in Methods. Mean 
values d~ S.D. Data were derived from nonlinear regression analysis by using the mathematical equation given 
in Methods. 
lated to the presence of blood group antigen A in A431 
cells are not strictly comparable to those obtained on 
blood group A containing human red blood cells. It is 
known, for example, that there are differences in the 
structure of the antigen A containing oligosaccharide 
chains (type 1A in A431 cells [2] as compared to type 2A 
in human red blood cells [ 1 11) which could influence the 
binding of EGF. 
The EGF receptors of several other cell types do not 
appear to be glycosylated with ABH determinants [2,10]. 
However, these cell types (fibroblasts, Swiss 3T3 cells, 
and human placenta) are not known to contain ABH- 
antigen-like sugar structures on the proteins of their 
plasma membranes. In contrast, human erythrocytes are 
well known to bear these oligosaccharides on membrane 
proteins [ 5 ] .  The preliminary data presented in Table I 
indicate that in erythrocytes of blood group A, donors 
higher number of EGF binding sites are present. The 
simplest explanation of these results would be that the 
different ABH-antigens present on a hitherto not demon- 
strated EGF receptor of human erythrocytes might influ- 
ence the binding of EGF. Alternatively, ABH antigens 
present on red cell glycoproteins or glycolipids in close 
vicinity to the EGF binding site could modulate the inter- 
action of EGF with its binding site. 
Since only a low number of donors have been analyzed 
in the present investigation, the results require confirma- 
tion from studies performed on larger populations. Fur- 
thermore, it should also be investigated in future studies 
whether human red cells contain EGF receptors similar to 
those of other cell types (e.g., by immunoprecipitation of 
the phosphorylated receptor). Such experiments will be 
of particular importance in view of previous observations 
indicating that cells of the human hematopoietic system 
do not appear to express the EGF receptor [ 11. 
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